Crossmark

BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings

Crossref DOI link: https://doi.org/10.1186/s13063-023-07098-2

Published Online: 2023-02-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chaccour, Carlos https://orcid.org/0000-0001-9812-050X
Casellas, Aina https://orcid.org/0000-0003-4939-8411
Hammann, Felix https://orcid.org/0000-0003-0658-9330
Ruiz-Castillo, Paula

Nicolas, Patricia

Montaña, Julia

Mael, Mary

Selvaraj, Prashant

Duthaler, Urs

Mrema, Sigilbert

Kakolwa, Mwaka

Lyimo, Issa

Okumu, Fredros

Marathe, Achla

Schürch, Roger

Elobolobo, Eldo

Sacoor, Charfudin

Saute, Francisco

Xia, Kang

Jones, Caroline

Rist, Cassidy

Maia, Marta

Rabinovich, N. Regina https://orcid.org/0000-0003-1065-0173
Funding

Funding for this research was provided by:

Unitaid (BOHEMIA)
License Information

Text and Data Mining valid from 2023-02-21

Version of Record valid from 2023-02-21
More Information

Article History

Received: 19 November 2022

Accepted: 17 January 2023

First Online: 21 February 2023

Declarations

:

: This protocol has been reviewed and approved by the following committees:Additional approvals are also availableANARME, National regulatory authority of MozambiqueWritten informed consent to participate will be obtained from all participants

: Not applicable — no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below